Publications:93

Ivone A Gomes, PhD
About Me
Dr. Gomes is a member of the Devi Laboratory within the Department of Pharmacology and Systems Therapeutics.
Language
English
Position
ASSOCIATE PROFESSOR | Pharmacological Sciences
Education
BSc, Bombay University
MSc, Bombay University
PhD, All India Institute of Medical Sciences
Awards
1987
All India Institute of Medical Sciences Ph.D. Fellowship
Research
My primary research interests include the investigation of G-protein coupled receptor cross-talk and mechanisms involved in G-protein coupled receptor heterodimerization/oligomerization. We have shown that two functional receptors- mu and delta opioid receptors- associate with each other (i.e. heterodimerize) to form complexes with pharmacological and signaling properties quite distinct from each individual receptor. Occupancy of the delta opioid receptor with a low non-activating dose of selective delta drugs increases the binding and signaling properties of agonists acting at the mu receptors. This work provides a model for the development of a new generation of narcotic analgesics which would have a lower tendency to induce side-effects such as addiction and tolerance. We have also shown that mu opioid receptor signaling can be modulated by heterodimerization with either alpha 2A or CB1 cannabinoid receptors. We are currently investigating the mechanisms involved as well as the physiological relevance of receptor heterodimerization.
Publications
Selected Publications
- Identification of small molecule ligands for GPR83 that modulate morphine antinociception and reward. Ivone Gomes, Seshat M. Mack, Roberto Sanchez, Anubhav Yadav, Mariana L. Duarte, Lakshmi A. Devi, Amanda K. Fakira. Molecular Pharmacology
- Antidepressants and the endogenous opioid system. Lloyd D. Fricker, Aya Osman, Achla Gupta, Ivone Gomes, Lakshmi A. Devi. Biochemical Pharmacology
- Endothelin-converting enzyme 2 regulates κ opioid receptor trafficking and function. Achla Gupta, Ivone Gomes, Salvador Sierra, Aya Osman, Lakshmi A. Devi. Journal of Pharmacology and Experimental Therapeutics
Industry Relationships
Physicians and scientists on the faculty of the Icahn School of Medicine at Mount Sinai often interact with pharmaceutical, device, biotechnology companies, and other outside entities to improve patient care, develop new therapies and achieve scientific breakthroughs. In order to promote an ethical and transparent environment for conducting research, providing clinical care and teaching, Mount Sinai requires that salaried faculty inform the School of their outside financial relationships.
Dr. Gomes has not yet completed reporting of industry relationships or has no industry relationships to report.
Mount Sinai’s faculty policies relating to faculty collaboration with industry are posted on our website. Patients may wish to ask their physician about the activities they perform for companies.